XML 51 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Derivatives
3 Months Ended
Mar. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Derivative Financial Instruments
The following table summarizes the terms and fair values of the Company's derivative financial instruments, as well as their classification on the Consolidated Balance Sheets, as of March 31, 2013 and December 31, 2012 (in thousands): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair Value
 
Effective Date
 
Maturity Date
 
Early Termination Date (1)
 
Counterparty
 
Notional Amount
 
Bank Pays Variable Rate of
 
Regency Pays Fixed Rate of
 
2013
 
2012
Assets:
 
4/15/14
 
4/15/24
 
10/15/14
 
JPMorgan Chase Bank, N.A.
$
75,000

 
3 Month LIBOR
 
2.087%
$
1,732

 
1,022

 
4/15/14
 
4/15/24
 
10/15/14
 
Bank of America, N.A.
 
50,000

 
3 Month LIBOR
 
2.088%
 
1,147

 
672

 
8/1/15
 
8/1/25
 
2/1/16
 
US Bank National Association
 
75,000

 
3 Month LIBOR
 
2.479%
 
2,081

 
1,131

 
8/1/15
 
8/1/25
 
2/1/16
 
Royal Bank of Canada
 
50,000

 
3 Month LIBOR
 
2.479%
 
1,344

 
729

 
8/1/15
 
8/1/25
 
2/1/16
 
PNC Bank, N.A.
 
50,000

 
3 Month LIBOR
 
2.479%
 
1,375

 
753

Other Assets
 
 
 
 
 
 
 
 
$
7,679

 
4,307

Liabilities:
 
10/1/11
 
9/1/14
 
N/A
 
PNC Bank, N.A.
$
9,000

 
1 Month LIBOR
 
0.760%
$
(64
)
 
(76
)
Accounts payable and other liabilities
 
$
(64
)
 
(76
)
(1) Represents the date specified in the agreement for either optional or mandatory early termination which will result in cash settlement.
These derivative financial instruments are comprised of interest rate swaps, which are designated and qualify as cash flow hedges. The Company does not use derivatives for trading or speculative purposes and currently does not have any derivatives that are not designated as hedges. The derivative instruments are subject to master netting agreements, however the Company does not have multiple derivatives with the same counterparties, therefore none are offset in the accompanying Consolidated Balance Sheet.
The Company has $150.0 million of unsecured long-term debt that matures in 2014 and $350.0 million of unsecured long-term debt that matures in 2015. In order to mitigate the risk of interest rates rising before new unsecured borrowings are obtained, the Company entered into five forward-starting interest rate swaps during December 2012, for the same ten year periods expected for the future borrowings. These swaps total $300.0 million of notional value, as shown above as assets at March 31, 2013. The Company will settle these swaps upon maturity, which is expected to coincide with the date new unsecured borrowings are obtained, and will begin amortizing the gain or loss realized from the swap settlement over the ten year period expected for the new borrowings; resulting in a modified effective interest rate on those borrowings.
The effective portion of changes in the fair value of derivatives designated and qualifying as cash flow hedges is recorded in accumulated other comprehensive income (loss) and subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings as a gain or loss on derivative instruments.

The following table represents the effect of the derivative financial instruments on the accompanying consolidated financial statements for the three months ended March 31, 2013 and 2012 (in thousands):
 
Derivatives in FASB
ASC Topic 815 Cash
Flow Hedging
Relationships:
Amount of Gain (Loss)
Recognized in OCI on
Derivative (Effective
Portion)
 
Location of Gain
(Loss) Reclassified
from Accumulated
OCI into Income
(Effective Portion)
 
Amount of Gain (Loss)
Reclassified from
Accumulated OCI into
Income (Effective
Portion)
 
Location of Gain or
(Loss) Recognized in
Income on  Derivative
(Ineffective Portion and
Amount Excluded from
Effectiveness Testing)
 
Amount of Gain or
(Loss) Recognized in
Income on Derivative
(Ineffective Portion and
Amount Excluded from
Effectiveness Testing)
 
March 31,
 
 
 
March 31,
 
 
 
March 31,
 
2013
 
2012
 
 
 
2013
 
2012
 
 
 
2013
 
2012
Interest rate swaps
$
3,372

 
34

 
Interest
expense
 
$
(2,367
)
 
(2,364
)
 
Other expenses
 
$

 
(3
)

As of March 31, 2013, the Company expects $9.5 million of deferred losses (gains) on derivative instruments accumulated in other comprehensive income to be reclassified into earnings during the next 12 months.